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Background
Triple-transgenic mice (3xTgAD) overexpressing Swed-
ish-mutated b-amyloid-precursor-protein (APPswe),
P310L-Tau (TauP301L) and physiological levels of M146V-
presenilin-1 (PS1M146V) display extracellular amyloid-beta
peptides (Abeta) deposits and Tau tangles at late ages.
These mice also show an early, age-dependent and hippo-
campus specific accumulation of intra-neuronal APP-
related materiel, which was firstly reported to correspond
to Abeta. However, more recent work has disputed the
presence of intra-neuronal Abeta and questioned its role
in synaptic pathology and behavior.
Material and methods
In the present work we used multiple approaches (bio-
chemical, immunohistological, genetic and pharmacologi-
cal) to determine the exact nature of the intracellularly
accumulating catabolite in the 3xTgAD. The 3xTgAD and
nonTg were provided by Dr.LaFerla and the 2xTgAD
mice were obtained by firstly crossing 3xTgAD and nonTg
mice and then inter-crossing the F1 progeny. One group
of mice was treated by oral gavage with the gamma-secre-
tase inhibitor (ELND006, Elan Pharm.) during 2 weeks.
Results
Here we identify the beta-secretase-derived C-terminal
fragment of APP (C99) as the earliest APP catabolite and
main contributor to the intracellular APP-related immu-
noreactivity in 3xTgAD mice. C99 is detected as early as
about 3 months of age which is several months before
intracellular Abeta can be detected. C99 accumulation
occurs mainly in the CA1/subicular interchange area of
the hippocampus corresponding to the first region exhibit-
ing plaques and tangles in old mice. In other regions such
as the cortex, C99 does not accumulate with age, although
APP is expressed to similar levels. We show that C99
accumulation is not linked to a defective gamma-secretase
processing. First of all, gamma-secretase activity is identi-
cal in the hippocampus and the cortex. Second of all, mice
lacking the FAD PS1 mutant knock-in (2xTgAD) similarly
accumulate C99 indicating that the accumulation is not
triggered by the PS1 mutation. Finally, pharmacological
inhibition of the gamma-secretase rapidly and importantly
raises the levels of C99 in young mice.
Conclusions
Altogether, our work identifies C99 as the first and main
APP catabolite accumulating intra-cellularly in the
3xTgAD mouse suggesting its role as a key initiator and
determinant for intra-neuronal pathology in the 3xTgAD
mouse.
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